Company Search:
Advanced Search
Sponsored Links
Hangzhou Tigermed Consulting Co Ltd Company Snapshot
Hangzhou Tigermed Consulting Co Ltd operates in the Medical laboratories sector. In addition to historical fundamental analyses, the complete report available to purchase compares Hangzhou Tigermed Consulting Co Ltd with three other pharmaceutical manufacturers in Asia: Prodia Widyahusada Tbk PT of Indonesia (2017 sales of 1.47 trillion Indonesian Rupiahs [US$101.89 million] ), Falco Holdings Co Ltd of Japan (45.97 billion Japanese Yen [US$405.92 million] of which 61% was Medical Test), and Dr. Lal PathLabs Ltd which is based in India (9.12 billion Indian Rupees [US$129.28 million] of which 100% was Healthcare).

Sales Analysis. Hangzhou Tigermed Consulting Co Ltd reported sales of 1.69 billion Chinese Renmimbi (US$246.04 million) for the year ending December of 2017. This represents an increase of 43.6% versus 2016, when the company's sales were 1.17 billion Chinese Renmimbi. Sales at Hangzhou Tigermed Consulting Co Ltd have increased during each of the previous five years (and since 2012, sales have increased a total of 581%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Hangzhou Tigermed Consulting Co Ltd
  Stock Performance Chart for Hangzhou Tigermed Consulting Co Ltd
  Stock Data: Recent Stock Performance:
  Current Price (12/7/2018): 46.47
(Figures in Chinese Renmimbi)
1 Week -4.4%   13 Weeks 3.3%  
4 Weeks -13.6%   52 Weeks 51.1%  
Hangzhou Tigermed Consulting Co Ltd Key Data:
  Ticker: 300347 Country: China
  Exchanges: SZN Major Industry: Health Care Equipment & Services
    Sub Industry: Medical Laboratories
  2017 Sales 1,687,032,929
(Year Ending Jan 2018).
Employees: 3,214
  Currency: Chinese Renmimbi Market Cap: 23,243,203,674
  Fiscal Yr Ends: December Shares Outstanding: 500,176,537
  Share Type: A Gu Closely Held Shares:
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.